Company Filing History:
Years Active: 1988-1993
Title: Inventor Profile: Cheryl D. Schwartz from Westfield, NJ
Introduction
Cheryl D. Schwartz is a prominent inventor based in Westfield, New Jersey, recognized for her significant contributions to the field of pharmaceuticals, particularly in the development of compounds to address panic and anxiety disorders. With a remarkable portfolio of seven patents, her work demonstrates a strong commitment to advancing medical science.
Latest Patents
Schwartz's latest patents include innovative pharmaceutical compositions that leverage fermentation analogs of Virginiamycin M.sub.1. These compositions are particularly beneficial in treating panic disorders and anxiety disorders. Her work details the various analogs of Virginiamycin M.sub.1 which act as antagonists of cholecystokinin (CCK) and gastrin. This research has promising implications as CCK antagonists are useful not only as analgesics but also in the treatment and prevention of disorders affecting the gastrointestinal and central nervous systems of animals, especially humans. Additionally, the compounds of Formulae I-IV are positioned as effective antibiotics and antimicrobial agents, suggesting their utility as food additives to enhance feed utilization in livestock.
Career Highlights
Cheryl Schwartz currently works with Merck & Company, Inc., a leading global healthcare company dedicated to saving and improving lives through innovative medicines. Her contributions to the organization further solidify her reputation as an influential figure in pharmaceutical innovation.
Collaborations
Throughout her career, Cheryl has collaborated with esteemed colleagues, including Otto D. Hensens and Yiu-kuen T. Lam. These professional relationships have fostered a collaborative environment that enhances research and development efforts within the pharmaceutical sector.
Conclusion
In summary, Cheryl D. Schwartz stands out as a key innovator in the field of pharmaceuticals, with a focus on developing critical therapeutic agents for mental health and gastrointestinal disorders. Her extensive patent portfolio and ongoing contributions to Merck & Company, Inc. underscore her role as a vital force in the medical research community.